Bouhamdan M - Search Results

1

The HIV-1 Vpr co-activator induces a conformational change in TFIIB.

Agostini I, Navarro JM, Bouhamdan M, Willetts K, Rey F, Spire B, Vigne R, Pomerantz R, Sire J. Agostini I, et al. Among authors: bouhamdan m. FEBS Lett. 1999 May 7;450(3):235-9. doi: 10.1016/s0014-5793(99)00501-3. FEBS Lett. 1999. PMID: 10359081 Free article.

2

Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme.

Bouhamdan M, Benichou S, Rey F, Navarro JM, Agostini I, Spire B, Camonis J, Slupphaug G, Vigne R, Benarous R, Sire J. Bouhamdan M, et al. J Virol. 1996 Feb;70(2):697-704. doi: 10.1128/JVI.70.2.697-704.1996. J Virol. 1996. PMID: 8551605 Free PMC article.

3

The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.

Agostini I, Navarro JM, Rey F, Bouhamdan M, Spire B, Vigne R, Sire J. Agostini I, et al. Among authors: bouhamdan m. J Mol Biol. 1996 Sep 6;261(5):599-606. doi: 10.1006/jmbi.1996.0485. J Mol Biol. 1996. PMID: 8800208

4

A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells.

Rey F, BouHamdan M, Navarro JM, Agostini I, Willetts K, Bouyac M, Tamalet C, Spire B, Vigne R, Sire J. Rey F, et al. Among authors: bouhamdan m. J Gen Virol. 1998 May;79 ( Pt 5):1083-7. doi: 10.1099/0022-1317-79-5-1083. J Gen Virol. 1998. PMID: 9603322

5

Diversity of HIV-1 Vpr interactions involves usage of the WXXF motif of host cell proteins.

BouHamdan M, Xue Y, Baudat Y, Hu B, Sire J, Pomerantz RJ, Duan LX. BouHamdan M, et al. J Biol Chem. 1998 Apr 3;273(14):8009-16. doi: 10.1074/jbc.273.14.8009. J Biol Chem. 1998. PMID: 9525900 Free article.

6

A novel Vpr peptide interactor fused to integrase (IN) restores integration activity to IN-defective HIV-1 virions.

Kulkosky J, BouHamdan M, Geist A, Pomerantz RJ. Kulkosky J, et al. Among authors: bouhamdan m. Virology. 1999 Mar 1;255(1):77-85. doi: 10.1006/viro.1998.9544. Virology. 1999. PMID: 10049823 Free article.

7

Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.

BouHamdan M, Kulkosky J, Duan LX, Pomerantz RJ. BouHamdan M, et al. J Hum Virol. 2000 Jan-Feb;3(1):6-15. J Hum Virol. 2000. PMID: 10774802

8

Human immunodeficiency virus type 1 Vpr alters bone marrow cell function.

Kulkosky J, Laptev A, Shetty S, Srinivasan A, BouHamdan M, Prockop DJ, Pomerantz RJ. Kulkosky J, et al. Among authors: bouhamdan m. Blood. 1999 Mar 15;93(6):1906-15. Blood. 1999. PMID: 10068663 Free article.

9

Pathogenesis of HIV-1 infection within bone marrow cells.

Kulkosky J, Bouhamdan M, Geist A, Nunnari G, Phinney DG, Pomerantz RJ. Kulkosky J, et al. Among authors: bouhamdan m. Leuk Lymphoma. 2000 May;37(5-6):497-515. doi: 10.3109/10428190009058502. Leuk Lymphoma. 2000. PMID: 11042510 Review.

10

Inhibition of HIV type 1 replication in chronically infected monocytes and lymphocytes by retrovirus-mediated gene transfer of anti-Rev single-chain variable fragments.

Ho WZ, Lai JP, Bouhamdan M, Duan L, Pomerantz RJ, Starr SE. Ho WZ, et al. Among authors: bouhamdan m. AIDS Res Hum Retroviruses. 1998 Nov 20;14(17):1573-80. doi: 10.1089/aid.1998.14.1573. AIDS Res Hum Retroviruses. 1998. PMID: 9840290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters